Increased expression of RSRC2 has been observed in neuroblastomas harboring somatic gain of chromosome 12q [38], and a MIER2-RSRC1 fusion has been observed in prostate cancer [39]. This evidence concerns the gene RSRC2 and neuroblastoma.